Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells

Eun Yi Moon, Su Young Oh, Gyoon Hee Han, Chul Sang Lee, Song Kyu Park

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This study demonstrates that cyclic AMP (cAMP) production is induced by lipopolysaccharide (LPS) stimulation and activates two different pathways in murine BV2 microglial cells. Two principal effector proteins for cAMP are protein kinase A (PKA) and cAMP-responsive guanine nucleotide exchange factor (Epac), a Rap GDP exchange factor. When cells were treated with various cAMP level modulators, nitric oxide (NO) production increased as the result of posttreatment with Type IV phosphodiesterase (PDE4) inhibitor, rolipram or dibutyryl-cAMP (dbcAMP), at 2 hr after LPS stimulation. Intracellular cAMP increased due to LPS stimulation and the cAMP modulators phosphorylate transcription factor CREB, which is enhanced in turn by posttreatment with dbcAMP. In contrast, the Epac-specific cAMP analog 8-(4-chloro-phenylthio)- 2′-O-methyladenosine-3′,5′-cyclic monophosphate (8CPT-2Me-cAMP) activates Rap1 in the BV2 cells, but does not induce PKA activation, as judged by CREB phosphorylation. NO production was enhanced by posttreatment with dbcAMP but not by treatment with 8CPT-2Me-cAMP. This suggests that LPS-stimulated NO production is mainly PKA-dependent and also that Epac1-mediated Rap1 activation is not required for the induction of NO production.

Original languageEnglish
Pages (from-to)38-44
Number of pages7
JournalJournal of Neuroscience Research
Volume81
Issue number1
DOIs
Publication statusPublished - 2005 Jul 1

Fingerprint

Cyclic AMP
Nitric Oxide
Lipopolysaccharides
Cyclic AMP-Dependent Protein Kinases
Guanine Nucleotide Exchange Factors
Phosphodiesterase 4 Inhibitors
Rolipram
Adenylate Kinase
Bucladesine
Phosphodiesterase Inhibitors
Transcription Factors
Phosphorylation

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience

Cite this

@article{5cdd10d8e5444777ac82cd7bd943b1b8,
title = "Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells",
abstract = "This study demonstrates that cyclic AMP (cAMP) production is induced by lipopolysaccharide (LPS) stimulation and activates two different pathways in murine BV2 microglial cells. Two principal effector proteins for cAMP are protein kinase A (PKA) and cAMP-responsive guanine nucleotide exchange factor (Epac), a Rap GDP exchange factor. When cells were treated with various cAMP level modulators, nitric oxide (NO) production increased as the result of posttreatment with Type IV phosphodiesterase (PDE4) inhibitor, rolipram or dibutyryl-cAMP (dbcAMP), at 2 hr after LPS stimulation. Intracellular cAMP increased due to LPS stimulation and the cAMP modulators phosphorylate transcription factor CREB, which is enhanced in turn by posttreatment with dbcAMP. In contrast, the Epac-specific cAMP analog 8-(4-chloro-phenylthio)- 2′-O-methyladenosine-3′,5′-cyclic monophosphate (8CPT-2Me-cAMP) activates Rap1 in the BV2 cells, but does not induce PKA activation, as judged by CREB phosphorylation. NO production was enhanced by posttreatment with dbcAMP but not by treatment with 8CPT-2Me-cAMP. This suggests that LPS-stimulated NO production is mainly PKA-dependent and also that Epac1-mediated Rap1 activation is not required for the induction of NO production.",
author = "Moon, {Eun Yi} and Oh, {Su Young} and Han, {Gyoon Hee} and Lee, {Chul Sang} and Park, {Song Kyu}",
year = "2005",
month = "7",
day = "1",
doi = "10.1002/jnr.20535",
language = "English",
volume = "81",
pages = "38--44",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells. / Moon, Eun Yi; Oh, Su Young; Han, Gyoon Hee; Lee, Chul Sang; Park, Song Kyu.

In: Journal of Neuroscience Research, Vol. 81, No. 1, 01.07.2005, p. 38-44.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells

AU - Moon, Eun Yi

AU - Oh, Su Young

AU - Han, Gyoon Hee

AU - Lee, Chul Sang

AU - Park, Song Kyu

PY - 2005/7/1

Y1 - 2005/7/1

N2 - This study demonstrates that cyclic AMP (cAMP) production is induced by lipopolysaccharide (LPS) stimulation and activates two different pathways in murine BV2 microglial cells. Two principal effector proteins for cAMP are protein kinase A (PKA) and cAMP-responsive guanine nucleotide exchange factor (Epac), a Rap GDP exchange factor. When cells were treated with various cAMP level modulators, nitric oxide (NO) production increased as the result of posttreatment with Type IV phosphodiesterase (PDE4) inhibitor, rolipram or dibutyryl-cAMP (dbcAMP), at 2 hr after LPS stimulation. Intracellular cAMP increased due to LPS stimulation and the cAMP modulators phosphorylate transcription factor CREB, which is enhanced in turn by posttreatment with dbcAMP. In contrast, the Epac-specific cAMP analog 8-(4-chloro-phenylthio)- 2′-O-methyladenosine-3′,5′-cyclic monophosphate (8CPT-2Me-cAMP) activates Rap1 in the BV2 cells, but does not induce PKA activation, as judged by CREB phosphorylation. NO production was enhanced by posttreatment with dbcAMP but not by treatment with 8CPT-2Me-cAMP. This suggests that LPS-stimulated NO production is mainly PKA-dependent and also that Epac1-mediated Rap1 activation is not required for the induction of NO production.

AB - This study demonstrates that cyclic AMP (cAMP) production is induced by lipopolysaccharide (LPS) stimulation and activates two different pathways in murine BV2 microglial cells. Two principal effector proteins for cAMP are protein kinase A (PKA) and cAMP-responsive guanine nucleotide exchange factor (Epac), a Rap GDP exchange factor. When cells were treated with various cAMP level modulators, nitric oxide (NO) production increased as the result of posttreatment with Type IV phosphodiesterase (PDE4) inhibitor, rolipram or dibutyryl-cAMP (dbcAMP), at 2 hr after LPS stimulation. Intracellular cAMP increased due to LPS stimulation and the cAMP modulators phosphorylate transcription factor CREB, which is enhanced in turn by posttreatment with dbcAMP. In contrast, the Epac-specific cAMP analog 8-(4-chloro-phenylthio)- 2′-O-methyladenosine-3′,5′-cyclic monophosphate (8CPT-2Me-cAMP) activates Rap1 in the BV2 cells, but does not induce PKA activation, as judged by CREB phosphorylation. NO production was enhanced by posttreatment with dbcAMP but not by treatment with 8CPT-2Me-cAMP. This suggests that LPS-stimulated NO production is mainly PKA-dependent and also that Epac1-mediated Rap1 activation is not required for the induction of NO production.

UR - http://www.scopus.com/inward/record.url?scp=23744510710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744510710&partnerID=8YFLogxK

U2 - 10.1002/jnr.20535

DO - 10.1002/jnr.20535

M3 - Article

C2 - 15931667

AN - SCOPUS:23744510710

VL - 81

SP - 38

EP - 44

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 1

ER -